Investigating the clinical potential for 14-3-3 zeta protein to serve as a biomarker for epithelial ovarian cancer

OBJECTIVE: Recently, 14-3-3 zeta protein was identified as a potential serum biomarker of epithelial ovarian cancer (EOC). The goal of this study was to investigate the clinical potential of 14-3-3 zeta protein for monitoring EOC progression compared with CA-125 and HE4. DESIGN: Prospective follow-u...

Descripción completa

Detalles Bibliográficos
Autores principales: Hatzipetros, Ioannis, Gocze, Peter, Koszegi, Tamas, Jaray, Akos, Szereday, Laszlo, Polgar, Beata, Farkas, Nelli, Farkas, Balint
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835546/
https://www.ncbi.nlm.nih.gov/pubmed/24238270
http://dx.doi.org/10.1186/1757-2215-6-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835546/
https://www.ncbi.nlm.nih.gov/pubmed/24238270
http://dx.doi.org/10.1186/1757-2215-6-79

Ejemplares similares